Logo Image
NP/PA Connect
News
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Conference CoverageConference ListingNP/PA Conferences
Events
NP/PA EventsCase-Based Roundtable
More
Publication
Dermatology Times
CME/CE
Resources
Awareness SpotlightInteractive ToolsJob BoardPartner PerspectivesPerspectives in DermatologyPollsSponsored ContentSponsored ResourcesSpot Test
Editorial Advisory Board
Partners

Subscribe

  • NP/PA Connect
  • News
  • Watch
  • Conferences
  • Events
  • Publication
  • CME/CE
  • Resources
  • Editorial Advisory Board
  • Partners
  • Subscribe
  • Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Anti-Aging
  • Artificial Intelligence
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hair & Scalp
  • Hidradenitis Suppurativa
  • Melasma
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
    • Non-Melanoma Skin Cancers
  • Vitiligo
  • Wound Care
Spotlight -
NP/PA Connect|
Acne|
Atopic Dermatitis|
Chronic Hand Eczema|
Chronic Spontaneous Urticaria|
Drug Watch|
Hidradenitis Suppurativa|
Psoriasis|
Skin Cancer|
Vitiligo
Advertisement

Girish Gupta, MB ChB, FRCP

Advertisement

Articles by Girish Gupta, MB ChB, FRCP

85% of Survey Respondents Do Not Know What Actinic Keratosis Is

ByKaitlyn Bader, Senior Editor ,Girish Gupta, MB ChB, FRCP
September 28th 2023

The survey conducted by Almirall included participants in the US and Europe.

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Dermatology Times

    1

    Veradermics Reports Sustained Hair Growth With VDPHL01 at 1 Year

    2

    Updated HS Guidelines Emphasize Biologics and Early Intervention

    3

    Brepocitinib Clears Skin in 69% of Cutaneous Sarcoidosis Patients

    4

    PASI 100 Rates and Site-Specific Responses With Oral Psoriasis Therapies

    5

    Litifilimab Improves Cutaneous Lupus Symptoms Through 52 Weeks

    • About
    • Advertise
    • Contact Us
    • Job Board
    • Do Not Sell My Information
    • Terms and Conditions
    • Privacy Policy
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    Brand Logo

    © 2026 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us